News and Trends 19 Nov 2016 Looking for outperforming cell lines ? CHOvolution is an all-in-one kit for GMP Bioproduction …therapeutic antibody’s development due to the similarity of the cells to human cells (e.g. folding, glycosylation etc). For example, CHO-K1-based cell lines, derived from the ovarian cells of the Chinese… November 19, 2016 - 4 minutesmins - By Dani Bancroft Share WhatsApp Twitter Linkedin Email
News and Trends 17 Jun 2022 ImCheck raises €96M in funding round …The Marseille-based company hopes it will reach a wider range of cancer immunotherapy with the antibody drugs that include a lead candidate in the development for liquid and solid tumors. … June 17, 2022 - 3 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
Interview 14 Nov 2022 In depth interview: AstraZeneca/Sanofi RSV drug Beyfortus …long-acting antibody designed for all infants for protection against RSV disease from birth through their first RSV season with a single dose, is being developed jointly by AstraZeneca and Sanofi… November 14, 2022 - 9 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
In Depth 15 Feb 2024 Turning the tide: recent advancements in childhood cancer research …the formation of a tumor. As neuroblastomas predominantly express the molecule GD2, Renaissance’s lead candidate Hu14.18 is a humanized, anti-GD2 antibody. When an anti-GD2 antibody is combined with chemotherapy in… February 15, 2024 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 5 Mar 2018 Danish Biotech Starts Phase III Atopic Dermatitis Trial With Failed Asthma Treatment Danish biotech LEO Pharma started a Phase III trial in atopic dermatitis with an antibody that AstraZeneca dropped after failing two Phase III trials in asthma. LEO Pharma is taking… March 5, 2018 - 2 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
Best in Biotech 22 Dec 2021 The Biggest European Biotech News of 2021 …to be absorbed into the US firm Enbiotix after disappointing results from drug candidates for bacterial infections and cancer. Meanwhile, fresh waves of Covid-19 dog efforts to return to normality…. December 22, 2021 - 10 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 12 Oct 2022 Novavax COVID-19 vaccine data supports homologous and heterologous boosting …a type of antibody) levels increased significantly relative to pre-boost levels, rising above the level correlated with 95% vaccine efficacy in a recent USG study. Neutralizing antibodies against the prototype… October 12, 2022 - 3 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
Interview 17 Apr 2017 Meet One of the Most Successful German Biotech Leaders Ever …looked like a disaster in the first place, created the opportunity to develop a bispecific T cell-engaging antibody that was in-licensed from inventors at Munich’s LMU. This antibody ultimately became… April 17, 2017 - 6 minutesmins - By Philip Hemme Share WhatsApp Twitter Linkedin Email
In Depth 15 Aug 2025 How biotech is improving the life of your cat …from human or canine drugs isn’t a durable option. If you give a cat a human or dog-like antibody, the cat’s immune system may attack it. So, companies build the… August 15, 2025 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 30 Aug 2017 German Scientists Publish New Mechanism of Action Against Alzheimer’s …developing a therapeutic antibody with a unique mode of action against Alzheimer’s, PBD-C06. The company announced yesterday the publication in the Journal of Biological Chemistry of the detailed binding mechanism… August 30, 2017 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 13 Oct 2022 Merck contributing to Jacobio Pharma colorectal cancer clinical trial …treatment; combination therapy with SHP2 inhibitor, PD-1 monoclonal antibody and cetuximab. About Erbitux (cetuximab) Erbitux is an IgG1 monoclonal antibody targeting the epidermal growth factor receptor (EGFR). As a monoclonal… October 13, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 14 Jul 2022 GenScript ProBio enters strategic partnerships with two South Korean biotechs …DAAN Bio Therapeutics Based in Seoul, South Korea, DAAN Bio Therapeutics has developed an integrated immune-oncology drug research platform for the discovery of novel antibody and cell therapy drugs for… July 14, 2022 - 3 minutesmins - By Omnia Ibrahim Share WhatsApp Twitter Linkedin Email